BCR::ABL1 kinase domain mutations and their predictive value for treatment outcomes in patients with chronic myeloid leukemia treated with first-line imatinib in a low-income setting: Experience from Côte d'Ivoire
BCR::ABL1激酶结构域突变及其对低收入地区接受一线伊马替尼治疗的慢性粒细胞白血病患者疗效的预测价值:来自科特迪瓦的经验
期刊:Leukemia Research Reports
影响因子:0.9
doi:10.1016/j.lrr.2025.100544
Koffi, Kouassi Gustave; Bognini, Sara Akou; Silué, Dohoma Alexis; Kamara, Ismael; Kouakou, Ines; Dieket, Ruth; N'dhatz, Emeraude; Kouakou, Boidy; Nanho, Danho Clotaire; Kouassi, Yannick; Okou, David Tea